Navigation Links
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
Date:1/22/2009

in patients with AML."

About CPX-351

CPX-351 represents a new approach to developing combinations of drugs in which drug molar ratios with synergistic anti-tumor activity are encapsulated in a drug delivery vehicle in order to maintain the desired ratio following administration. CPX-351 has been granted orphan drug status by the U.S. Food & Drug Administration (FDA) for the treatment of AML and is currently being studied in a randomized trial comparing CPX-351 versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated AML.

About Acute Myeloid Leukemia (AML)

The National Cancer Institute defines AML as a quickly progressing disease in which too many immature white blood cells (not lymphocytes) are found in the blood and bone marrow. In 2008, the American Cancer Society's Cancer Facts and Figures estimates 13,290 new cases of AML and 8,820 deaths.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. LLS's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 6.3 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit www.LLS.org or call LLS's Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resourc
'/>"/>

SOURCE Celator Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. Leukemia Drug Proves Safe and Effective Over the Long Term
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
11. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Ill. , June 18, 2013 /PRNewswire-iReach/ -- ... its new X3130 Appliance Inlet Module. The X3130, ... breaker , combines a C14 appliance inlet module, ... compact package.  This three-in-one device allows design engineers ... designs - cutting installation time by 66 percent ...
(Date:6/18/2013)... , June 18, 2013  It has become ... Alliance Seating and Mobility, a subsidiary company of ... timely repair. This appears to be due to ... of field service employees.  (Logo: ... many of these clients are complex mobility users ...
(Date:6/18/2013)...  Recent regulatory and budget challenges have made it ... large pharmaceutical companies to effectively educate doctors and other ... their new products. With the pressure to reduce budgets ... these "Med Ed" groups find practical, economical ... the changes that are transforming the Medical Education area ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
... SHANGHAI, Nov. 12, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech ... announced shareholder resolutions adopted at its annual general ... November 10, 2010. (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO) ... the meeting, WuXi PharmaTech shareholders approved the re-election ...
Cached Medicine Technology:HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 Kansas City will host ... Main Street Day . A section of Main Street in ... during the afternoon of the event. The Main Street Corridor ... event, which will help Kansas City join the ranks of dozens ... as a tool to foster community vibrancy and active lifestyles. , ...
(Date:6/19/2013)... June 19, 2013 Amerinet, Inc, ... ARAMARK Healthcare Technologies to help Pacific Medical Centers ... savings of more than 17 percent over the ... expenditures. , “Driving economies of scale and process ... management challenges facing multi-site providers,” said Shawn Padilla, ...
(Date:6/19/2013)... New data, published today in Menopause International ... experiencing less sex, and less satisfying sex compared ... they are considerably less likely to access appropriate ... atrophy1. , The first-of-its-kind study, called the CLarifying ... study, showed that British post-menopausal women with vaginal ...
(Date:6/19/2013)... derived from a naturally occurring compound (apocynin), has ... with Parkinson,s Disease symptoms by preventing deficits in ... the May 28, 2013 edition of ... postdoctoral fellow at the Medical College of Wisconsin ... Balaraman Kalyanaraman, Ph.D., Harry R. & Angeline ...
(Date:6/19/2013)... MA (PRWEB) June 19, 2013 ... , a premier kids entertainment media organization, and ... serious games company, will be introducing the Games ... StudenTopia. The 3D game is geared toward students ... eating and active lifestyles by rewarding positive choices. ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5
... DaVita Inc., a,leading provider of kidney care services ... kidney failure, is honored to receive the eHealthcare,Leadership ... the,Consumer/Disease-Focused category. DaVita.com was one of 1,100 entries,submitted ... program,recognizes websites in the healthcare industry such as ...
... BRIDGEWATER, N.J., Dec. 8 R&J Public Relations, a ... retained to engage in public relations initiatives to promote ... MAQUET is a leading global provider of medical ... technologies. , , ...
... Water is a critical ingredient in the manufacturing process ... quality water (HQW) is the single biggest driver for ... in the pharmaceutical sector. Frost & Sullivan,s European Environment ... wastewater management market in the European pharmaceutical industry has ...
... Cleveland Clinic,s Department of Orthopaedic Surgery, available for download as a PDF, ... ... (PRWEB) December 8, 2008 -- In 2008, 240,000 people in the United ... not inevitable. A new guide from Cleveland Clinic includes a multitude ...
... has joined the staff at the St. John-Clark Pain ... St. John, Randall Clark, Tracy Alan Jones, Brunella Lucchi ... rest of the clinic,s dream team. From chicago, ... recruiting top therapists from across the country who specialize ...
... , ... West Chester, PA (PRWEB) December 5, 2008-- ... of its Precious Metal tubing production capacity due to increasing demand ... metals - Platinum, in particular - are characterized by a high ...
Cached Medicine News:Health News:DaVita.com Receives eHealthcare Leadership Award 2Health News:R&J Public Relations Selected to Promote MAQUET Inc.'s VARIOP Operating Room Suite in North America 2Health News:Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 3Health News:The St. John-Clark Pain Treatment Center Forms Manual Therapy 'Dream Team' 2Health News:Johnson Matthey Medical Announces Expansion 2
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: